Acumen Pharma Presents Brain Delivery Studies at Alzheimer’s and Parkinson’s Diseases Conference 2026
By Karen Roman Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS) said it presented new research findings at...

By Karen Roman Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS) said it presented new research findings at...
By Daniella Parra Acumen Pharmaceuticals said it will present new research on its Alzheimer’s treatment...
By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it is collaborating with three new...
By Karen Roman Sequana Medical said the company now has five medical centers using its...
By Karen Roman SkylineDx said its Merlin CP-GEP molecular test is uniquely recognized by the National...
By Karen Roman Now Optics, the parent company of Stanton Optical, said it is opening...
By Exec Edge Editorial Staff Ascentage Pharma said China’s Center for Drug Evaluation has cleared...
By Daniella Parra Iovance Biotherapeutics said Amtagvi had a 52% response rate with two or...
By Karen Roman GlucoTrack, Inc. (Nasdaq: GCTK) said the U.S. Patent and Trademark Office issued...
By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it is collaborating with medical device...